Phase III trials examining the efficacy of cetirizine ophthalmic solution 0.24% compared to vehicle for the treatment of allergic conjunctivitis in the conjunctival allergen challenge model

PURPOSE: The purpose of these Phase III studies was to evaluate the efficacy and safety of cetirizine ophthalmic solution 0.24% compared with vehicle in the treatment of allergen-induced conjunctivitis using the Ora conjunctival allergen challenge (CAC)(®) model. METHODS: The single-center (Study 1)...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Ophthalmol
Hlavní autoři: Meier, Edward J, Torkildsen, Gail L, Gomes, Paul J, Jasek, Mark C
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2018
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6296187/
https://ncbi.nlm.nih.gov/pubmed/30587908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S185835
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky